Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Avalyn Pharma Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Pharmaceutical Preparations
No intraday reading yet this session.
AVLN (Avalyn Pharma Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
92 institutional managers report a position in Avalyn Pharma Inc. worth $1.4B between them, filed on form 13F for the quarter ending 2026-06-30. 18 of them hold 80% of it, the largest being FMR LLC at 13.26%.
67 more managers in the register
18 managers hold 80% of the $1.4B institutional base. The other 74 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Perceptive Advisors LLC, Suvretta Capital Management, LLC, T. Rowe Price Investment Management, Inc. +3 more · 6.08% of AVLN, 10.40% of IMTX
via SR One Capital Management, LP, Perceptive Advisors LLC, Deerfield Management Co +2 more · 7.52% of AVLN, 23.26% of MOBI
via SR One Capital Management, LP, NVP Associates, LLC, Wellington Management Group LLP +6 more · 7.52% of AVLN, 8.18% of ZBIO
via SR One Capital Management, LP, Suvretta Capital Management, LLC, Jennison Associates LLC +4 more · 7.52% of AVLN, 7.08% of MANE
via Novo A/S, T. Rowe Price Investment Management, Inc., Pivotal bioVenture Partners Investment Advisor LLC +3 more · 8.82% of AVLN, 14.03% of MPLT
via Wellington Management Group LLP, T. Rowe Price Investment Management, Inc., Deerfield Management Co +8 more · 5.00% of AVLN, 4.88% of DNTH
Managers holding a meaningful stake in AVLN also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.